Canada Rare Earth Corp said the first shipment of rare earth concentrate from a new supplier is in transit to its customer base. The company noted that this.
Canada Rare Earth Corp said the first shipment of rare earth concentrate from a new supplier is in transit to its customer base. The company noted that this.
maximally sustaining IL-6 suppression in a chronic disease like NMOSD and enabling subcutaneous dosing every four weeks. Positive Phase III results for ENSPRYNG, as both monotherapy and in. | March 25, 2022
First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presentedEvrysdi data continue
Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below - read this article along with other careers information, tips and advice on BioSpace